Medicare Enrolled

Dr. Allison Froehlich, MD

Endocrinology · Stroudsburg, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
600 COMMERCE BLVD, Stroudsburg, PA 18360
5704262330
In practice since 2007 (19 years)
NPI: 1962619189 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Froehlich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Froehlich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Froehlich

Dr. Allison Froehlich is an endocrinology specialist in Stroudsburg, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Froehlich performed 3,990 Medicare services across 739 unique beneficiaries.

Between the years covered by Open Payments, Dr. Froehlich received a total of $8,344 from 41 pharmaceutical and/or device companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Froehlich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in PA $8,344 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,990
Medicare services
Top 9% in PA for endocrinology
739
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~210 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,120 $18 $49
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
308 $79 $215
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
139 $127 $287
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
82 $25 $85
Urine microalbumin test
A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function.
56 $6 $10
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
53 $10 $65
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $110 $317
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
44 $9 $50
Telephone or electronic consultation, at least 5 minutes
A remote assessment and management service provided by a consulting physician via telephone, internet, or electronic health record. The service requires at least 5 minutes of time and includes a written report.
30 $23 $75
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
24 $25 $65
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
22 $48 $256
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
19 $29 $57
New patient office visit, complex (60-74 min) 16 $153 $402
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
15 $74 $125
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $53 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,344
Total received (2018-2024)
Avg $1,192/year across 7 years
Top 25% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
402
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,265 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$170
2023
$1,931
2022
$2,939
2021
$1,599
2020
$644
2019
$682
2018
$378

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tandem Diabetes Care, Inc.
$114
Medtronic, Inc.
$56
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,170
Novo Nordisk Inc
$797
Medtronic MiniMed, Inc.
$547
Lilly USA, LLC
$451
SANOFI-AVENTIS U.S. LLC
$426
Abbott Laboratories
$424
Boehringer Ingelheim Pharmaceuticals, Inc.
$421
AstraZeneca Pharmaceuticals LP
$362
Dexcom, Inc.
$353
Xeris Pharmaceuticals, Inc.
$310
Corcept Therapeutics
$282
Tandem Diabetes Care, Inc.
$249
Amgen Inc.
$220
MannKind Corporation
$203
Insulet Corporation
$133
Becton, Dickinson and Company
$116
Alexion Pharmaceuticals, Inc.
$99
Bayer Healthcare Pharmaceuticals Inc.
$79
Bayer HealthCare Pharmaceuticals Inc.
$74
Merck Sharp & Dohme Corporation
$63
DEXCOM, INC.
$61
Antares Pharma, Inc.
$59
Mannkind Corporation
$51
Radius Health, Inc.
$43
Embecta Corp.
$34
IBSA Pharma Inc.
$30
Horizon Therapeutics plc
$28
AbbVie, Inc.
$28
Kowa Pharmaceuticals America, Inc.
$26
Supernus Pharmaceuticals, Inc.
$24
Ultragenyx Pharmaceutical Inc.
$23
Ascendis Pharma Inc
$22
Valeritas, Inc.
$21
Amryt Pharma Holdings Ltd
$18
Amarin Pharma Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$16
Gilead Sciences, Inc.
$15
Merck Sharp & Dohme LLC
$14
Janssen Pharmaceuticals, Inc
$13
Eisai Inc.
$12
Covidien LP
$12
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · Capnostream · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Enlite Sensor · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GUARDIAN CONNECT · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · Livalo · MINIMED 630G · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · OTREXUP · Omnipod · Ozempic · RECORLEV · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · Saxenda · Strensiq · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · V-GO · Vascepa · Wegovy · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Stroudsburg?
Compare endocrinologists in the Stroudsburg area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
10
Per 100K population
6.0
County median income
$82,374
Nearest hospital
ST LUKE'S HOSPITAL - MONROE CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Froehlich is a mixed practice specialist, with above-average Medicare volume (top 9% in PA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Froehlich experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Froehlich performed 3,120 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Froehlich receive payments from pharmaceutical companies?
Yes. Dr. Froehlich received a total of $8,344 from 41 companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Froehlich's costs compare to other endocrinologists in Stroudsburg?
Dr. Froehlich's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Froehlich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →